Ahmad M. Alharbi

Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial

Mohammad Bosaeed, Ahmad M. Alharbi, Ebrahim Mahmoud et al. · Clinical Microbiology and Infection · 2022 · 103 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Antimicrobial Activity of Novel Deep Eutectic Solvents

Noor Akbar, Naveed Ahmed Khan, Taleb Ibrahim et al. · Scientia Pharmaceutica · 2023 · 35 citations · Full text

Life Sciences, Biochemistry, Antimicrobial Pharmacology +12

Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials

Noor Akbar, Muhammad Kawish, Naveed Ahmed Khan et al. · Antibiotics · 2022 · 24 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Effect of Microgravity on the Gut Microbiota Bacterial Composition in a Hindlimb Unloading Model

Ruqaiyyah Siddiqui, Rizwan Qaisar, Naveed Ahmed Khan et al. · Life · 2022 · 24 citations · Full text

Life Sciences, Biology, Microbiology +17

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

Mohammad Bosaeed, Ebrahim Mahmoud, Ahmad M. Alharbi et al. · Infectious Diseases and Therapy · 2021 · 22 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12